Skip to search formSkip to main contentSkip to account menu

Skeletal targeted radiotherapy

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Holmium-166 (166Ho)-DOTMP Skeletal Targeted Radiotherapy (STR™) with Melphalan and Autologous Peripheral Stem Cell Transplant (PBSCT) for Multiple Myeloma (MM).
Background:166Ho-DOTMP is a beta-emitting radiophosphonate that localizes specifically to the bone surfaces and can deliver high… 
2004
2004
166Ho-DOTMP Skeletal Targeted Radiotherapy with melphalan and autologous stem cell support for multiple myeloma.
6656 Background: 166Ho-DOTMP is a radiotherapeutic that localizes specifically to the skeleton and can deliver high dose… 
2003
2003
Dosimetry of high dose skeletal targeted radiotherapy (STR) with 166Ho-DOTMP.
A study was undertaken to determine the maximum tolerated dose of (166)Ho-DOTMP that could be administered safely, without… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)